References
- GroopmanJEItriLMChemotherapy-induced anemia in adults: incidence and treatmentJ Natl Cancer Inst199991191616163410511589
- MountziosGAravantinosGAlexopoulouZLessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemiaMol Clin Oncol20164221122026893865
- MacdougallICNovel erythropoiesis-stimulating agents: a new era in anemia managementClin J Am Soc Nephrol20083120020718077782
- StramerSLCurrent risks of transfusion-transmitted agents: a reviewArch Pat Lab Med20071315702707
- BernardACDavenportDLChangPKVaughanTBZwischenbergerJBIntraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patientsJ Am Coll Surg2009208593193719476865
- GalliLRicciCEganCGEpoetin beta for the treatment of chemotherapy-induced anemia: an updateOnco Targets Ther2015858359125784818
- MaenpaaJPuistolaURiskaHImpact of epoetin-beta on anemia and health-related quality of life in cancer patients: a prospective observational study using the generic 15D instrumentAnticancer Res20143452325232924778039
- CrathorneLHuxleyNHaasovaMThe effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia: a systematic review and economic modelHealth Technol Assess201620131632
- LittlewoodTJBajettaENortierJWVercammenERapoportBEpoetin Alfa Study GroupEffects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trialJ Clin Oncol200119112865287411387359
- OsterborgABrandbergYMolostovaVRandomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignanciesJ Clin Oncol200220102486249412011126
- BoogaertsMCoiffierBKainzCEpoetin Beta QOL Working GroupImpact of epoetin beta on quality of life in patients with malignant diseaseBr J Cancer200388798899512671693
- AaproMSAnemia management with erythropoiesis-stimulating agents: a risk-benefit updateOncologist200813Suppl 313
- European Medicines AgencyNeorecormon Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000116/human_med_000921.jsp&mid=WC0b01ac05-8001d124Accessed November 30, 2016
- BrinksVHaweABasmelehAHQuality of original and biosimilar epoetin productsPharm Res201128238639320886265
- European Generic Medicines AssociationBiosimilars Handbook2nd edLondonSage Publications Ltd2011
- Committee for Medicinal Products for Human UseGuideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003920.pdfAccessed April 29, 2016
- MichalletMLuporsiESoubeyranPBiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational studyBMC Cancer20141450325011615
- TheobaldKCapanMHerboldMSchinzelSHundtFQuality-assurance measures in non-interventional studiesGer Med Sci20097Doc29 Available from: http://www.egms.de/static/en/journals/gms/2009-7/000088.shtmlAccessed December 8, 201619949447
- RizzoJDBrouwersMHurlyPASCO-ASH clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancerJ Clin Oncol201028334996501020975064
- AaproMSLinkHSeptember 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agentsOncologist200813Suppl 3333618458123
- TheobaldKCapanMHerboldMSchinzelSHundtFQuality assurance in non-interventional studiesGer Med Sci2009729
- BokemeyerCAaproMSCourdiAEORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 updateEur J Cancer200743225827017182241
- AaproMJelkmannWConstantinescuSNLeyland-JonesBEffects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancerBrit J Cancer201210671249125822395661
- TzekovaVMihaylovGElezovicIKoytchevRTherapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemiaCurr Med Res Opin20092571689169719505200
- MichalletMLosemCBiosimilar epoetin zeta in oncology and haematology: development and experience following 6 years of useActa Haematol20161351445226426164